Testes in vivo nas reações de hipersensibilidade a medicamentos - Parte I: testes cutâneos
In vivo tests in hypersensitivity drug reactions - Part I: skin tests
Marcelo Vivolo Aun; Maria Fernanda Malaman; Mara Morelo Rocha Felix; Ullissis Pádua Menezes; Gladys Reis e Silva de Queiroz; Adriana Teixeira Rodrigues; Carolina Sanchez Aranda; Inês Cristina Camelo-Nunes; Dirceu Solé; Norma de Paula M. Rubini
Resumo
As reações de hipersensibilidade a medicamentos são frequentes na prática clínica e são consideradas problema de saúde pública. O diagnóstico inclui, após detalhada história clínica, a realização de testes in vivo: cutâneos ou de provocação. Recentemente, estes testes foram aprovados pela Câmara Técnica da Associação Médica Brasileira para inclusão tanto no SUS, como na Saúde Suplementar, o que facilitará o acesso dos pacientes a estas ferramentas. Nesta revisão, abordaremos com mais detalhes as indicações, técnica e impacto da utilização dos testes cutâneos com fármacos na prática clínica.
Palavras-chave
Keywords
Referências
1. Gruchalla RS. Drug Allergy. J Allergy Clin Immunol. 2003;S548‑59.
2. Greenberger PA. Drug Allergy. J Allergy Clin Immunol. 2006;S464‑70.
3. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al. International Consensus on drug allergy. Allergy. 2014;69:420-37.
4. Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug-induced exanthems. Curr Opin Allergy Clin Immunol. 2004;4:411-9.
5. Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol. 2007;7(4):299-303.
6. Gomes E, Cardoso MF, Praca F, Gomes L, Marino E, Demoly P. Self-reported drug allergy in a general adult Portuguese population. Clin Exp Allergy. 2004;34:1597-601.
7. Macy E. Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep. 2014;14(11):476.
8. Macy E, Shu YH. The effect of penicillin allergy testing on future health care utilization: a matched cohort study. J Allergy Clin Immunol Pract. 2017;5(3):705-10.
9. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity. Allergy. 1999;54(9):999-1003.
10. Demoly P, Kropf R, Bircher A, Pichler WJ. Hipersensibilidade a fármacos: questionário. Rev Port Imunoalergol. 2001;8(4):231-5.
11. Motta AA, Kalil J, Barros MT. Testes cutâneos. Rev Bras Alerg Imunopatol. 2005;28(3)73-83.
12. Fontaine C, Mayorga C, Bousquet PJ, Arnoux B, Torres MJ, Blanca M, et al. Relevance of the determination of serum-specific IgE antibodies in the diagnosis of immediate beta-lactam allergy. Allergy. 2007;62(1):47-52.
13. Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-12.
14. Bernd LAG. Alergia a Medicamentos. Rev Bras Alerg Imunopatol. 2005;28(3):125-32.
15. Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol. 2007;7(4):299-303.
16. Ministério da Saúde. Testes de sensibilidade a penicilina - manual, 1999. Disponível em: http://www.aids.gov.br.
17. Mirakian R, Leech SC, Krishna MT, Richter AG, Huber PA, Farooque S, et al. Management of allergy to penicillins and other beta-lactams. Clin Exp Allergy. 2015;45(2):300-27.
18. Hjortlund J, Mortz CG, Skov PS, Bindslev-Jensen C. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy. 2013;68(8):1057‑64.
19. Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology, the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactionsand the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int. 2015;24(3):94-105.
20. King EA, Challa S, Curtin P, Bielory L. Penicillin skin testing in hospitalized patients with β-lactam allergies: Effect on antibiotic selection and cost. Ann Allergy Asthma Immunol. 2016;117(1):67‑71.
21. Sacco KA, Bates A, Brigham TJ, Imam JS, Burton MC. Clinical outcomes following inpatient penicillin allergy testing: a systematic review and meta-analysis. Allergy. 2017;72(9):1288-96.
22. Blumenthal KG, Li Y, Banerji A, Yun BJ, Long AA, Walensky RP. The cost of penicillin allergy evaluation. J Allergy Clin Immunol Pract. 2018;6(3):1019-27.
23. http://portal.anvisa.gov.br/documents/374947/2829072/LISTA+CONFORMIDADE_2018-01-26.pdf/21a9b762-f2df-4715-bbb7-a588ddb9642d
Submetido em:
18/12/2018
Aceito em:
21/12/2018
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email